XML 15 R23.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Quarterly Financial Data (unaudited)
 12 Months Ended
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Data (unaudited) Quarterly Financial Data (unaudited)
The following table presents certain unaudited quarterly financial information. This information has been prepared on the same basis as the audited Consolidated Financial Statements and includes all adjustments necessary to present fairly the unaudited quarterly results of operations set forth herein.
 
2019
 
2018
 
Q1
 
Q2
 
Q3
 
Q4
 
Q1
 
Q2
 
Q3
 
Q4
Product revenue, net
$
20,362

 
$
27,164

 
$
35,743

 
$
28,375

 
$
606

 
$
2,265

 
$
7,176

 
$
14,070

Collaboration and license revenue
1,807

 
1,260

 
1,056

 
873

 
6,038

 
1,746

 
7,001

 
1,228

Operating expenses
(95,768
)
 
(92,384
)
 
(80,381
)
 
(119,391
)
 
(91,944
)
 
(107,706
)
 
(83,321
)
 
(102,479
)
Net loss
(78,096
)
 
(68,477
)
 
(49,627
)
 
(96,676
)
 
(84,510
)
 
(105,971
)
 
(71,177
)
 
(88,886
)
Net loss (income) attributable to noncontrolling interest (SRX Cardio)
(60
)
 
2,273

 
—

 
—

 
332

 
(223
)
 
(126
)
 
338

Net loss attributable to Portola
(78,156
)
 
(66,204
)
 
(49,627
)
 
(96,676
)
 
(84,178
)
 
(106,194
)
 
(71,303
)
 
(88,548
)
Net loss per share attributable to Portola common stockholders:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic and diluted
$
(1.17
)
 
$
(0.97
)
 
$
(0.68
)
 
$
(1.24
)
 
$
(1.28
)
 
$
(1.61
)
 
$
(1.08
)
 
$
(1.34
)